Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CILTACABTAGENE AUTOLEUCEL for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where CILTACABTAGENE AUTOLEUCEL was used for Neoplasm malignant.

Most Reported Side Effects for CILTACABTAGENE AUTOLEUCEL

Side Effect Reports % Deaths Hosp.
Cytokine release syndrome 570 15.0% 115 340
Pyrexia 242 6.4% 15 147
Immune effector cell-associated neurotoxicity syndrome 232 6.1% 78 126
Parkinsonism 209 5.5% 39 59
Hospitalisation 193 5.1% 0 191
Adverse event 143 3.8% 6 49
Neurotoxicity 140 3.7% 41 76
Death 130 3.4% 130 15
Malaise 126 3.3% 5 18
Fatigue 123 3.2% 6 21
Cranial nerve paralysis 115 3.0% 9 21
Facial paralysis 96 2.5% 9 46
Bell's palsy 95 2.5% 8 44
Haemophagocytic lymphohistiocytosis 91 2.4% 35 40
Pneumonia 87 2.3% 24 56

Other Indications for CILTACABTAGENE AUTOLEUCEL

Product used for unknown indication (2,451) Plasma cell myeloma (1,043) Plasma cell myeloma refractory (132) Plasma cell disorder (27) Diffuse large b-cell lymphoma (12) B-cell lymphoma (5)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

CILTACABTAGENE AUTOLEUCEL Full Profile All Neoplasm malignant Drugs CILTACABTAGENE AUTOLEUCEL Demographics CILTACABTAGENE AUTOLEUCEL Timeline